Association between serum fatty acids and lipoprotein subclass profile in healthy young adults: Exploring common genetic and environmental factors

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 394-402

  Jelenkovic, Aline ^a,b,c   Bogl, Leonie H ^c   Rose, Richard J ^d   Kangas, Antti J ^e   Soininen, Pasi ^e,f   Ala Korpela, Mika ^e,f,g,h   Kaprio, Jaakko ^c,i   Silventoinen, Karri ^c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c UNIVERSITY OF HELSINKI   (Finland)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF OULU   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g OULU UNIVERSITY HOSPITAL   (Finland)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

ⁱ NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Environmental factors; Genetic pleiotropy; Lipoprotein profile; Serum fatty acids; Twins

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; LINOLEIC ACID; LIPOPROTEIN; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; CHOLESTEROL; FAT INTAKE;

ADULT; ARTICLE; ENVIRONMENTAL FACTOR; FATTY ACID BLOOD LEVEL; FEMALE; GENETIC CORRELATION; GENETIC MODEL; HEREDITY; HERITABILITY; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLITE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; ADOLESCENT; BLOOD; BODY MASS; CLASSIFICATION; CROSS-SECTIONAL STUDY; DIZYGOTIC TWINS; EPIDEMIOLOGY; FAT INTAKE; FINLAND; FOLLOW UP; GENOTYPE ENVIRONMENT INTERACTION; MONOZYGOTIC TWINS; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PHENOTYPE; PLEIOTROPY; QUESTIONNAIRE; REFERENCE VALUE; SELF REPORT; TWINS; YOUNG ADULT;

ADOLESCENT; BODY MASS INDEX; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIETARY FATS; FATTY ACIDS; FINLAND; FOLLOW-UP STUDIES; GENE-ENVIRONMENT INTERACTION; GENETIC PLEIOTROPY; HUMANS; LIPOPROTEINS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PARTICLE SIZE; PHENOTYPE; QUESTIONNAIRES; REFERENCE VALUES; SELF REPORT; TRIGLYCERIDES; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; YOUNG ADULT;

EID: 84896306396     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.12.053     Document Type: Article

References (33)

1. Sharrett A.R., Ballantyne C.M., Coady S.A., et al. Atherosclerosis Risk in Communities Study Group. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001, 104:1108-1113.
2. Breuer H.W. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Curr Med Res Opin 2001, 17:60-73.
3. Harris W.S., Mozaffarian D., Rimm E., et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009, 119:902-907.
4. Balk E.M., Lichtenstein A.H., Chung M., Kupelnick B., Chew P., Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006, 189:19-30.
5. Ala-Korpela M. Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics. Clin Chem Lab Med 2008, 46:27-42.
6. Ala-Korpela M., Soininen P., Savolainen M.J. Letter by Ala-Korpela etal regarding article, "Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women". Circulation 2009, 120. [e149; author reply e150].
7. Jeyarajah E.J., Cromwell W.C., Otvos J.D. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006, 26:847-870.
8. Bogl L.H., Pietilainen K.H., Rissanen A., et al. Association between habitual dietary intake and lipoprotein subclass profile in healthy young adults. Nutr Metab Cardiovasc Dis 2013.
9. Annuzzi G., Rivellese A.A., Wang H., et al. Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study. Am J Clin Nutr 2012, 95:1315-1322.
10. Ferrucci L., Cherubini A., Bandinelli S., et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. JClin Endocrinol Metab 2006, 91:439-446.
11. Motoyama K.R., Curb J.D., Kadowaki T., et al. Association of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men. Am J Clin Nutr 2009, 90:49-55.
12. Wang S.P., Chen Y.H., Li H. Association between the levels of polyunsaturated fatty acids and blood lipids in healthy individuals. Exp Ther Med 2012, 4:1107-1111.
13. Choo J., Ueshima H., Curb J.D., et al. Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: the population-based cross-sectional ERA-JUMP study. Am J Clin Nutr 2010, 91:1195-1203.
14. Kettunen J., Tukiainen T., Sarin A.P., et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 2012, 44:269-276.
15. Kaprio J. Twin studies in Finland 2006. Twin Res Hum Genet 2006, 9:772-777.
16. Soininen P., Kangas A.J., Wurtz P., et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 2009, 134:1781-1785.
17. Tukiainen T., Kettunen J., Kangas A.J., et al. Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci. Hum Mol Genet 2012, 21:1444-1455.
18. Inouye M., Kettunen J., Soininen P., et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol 2010, 6:441.
19. Chambers J.C., Zhang W., Sehmi J., et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 2011, 43:1131-1138.
20. Tukiainen T., Tynkkynen T., Makinen V.P., et al. Amulti-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease. Biochem Biophys Res Commun 2008, 375:356-361.
21. Rao J.N.K., Scott A.J. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Ann Stat 1984, 12:46-60.
22. Neale M.C., Cardon L.R. Methodology for genetic studies of twins and families 2003, Kluwer, Dordrecht.
23. Neale M.C. Mx: statistical modeling 2003, Department of Psychiatry, University of Virginia, Richmond, VA.
24. Hodson L., Skeaff C.M., Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008, 47:348-380.
25. Wurtz P., Raiko J.R., Magnussen C.G., et al. High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis. Eur Heart J 2012, 33:2307-2316.
26. Rivellese A.A., Patti L., Kaufman D., et al. Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study. Atherosclerosis 2008, 200:350-358.
27. Skulas-Ray A.C., Kris-Etherton P.M., Harris W.S., Vanden Heuvel J.P., Wagner P.R., West S.G. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 2011, 93:243-252.
28. Emken E.A. Metabolism of dietary stearic acid relative to other fatty acids in human subjects. Am J Clin Nutr 1994, 60:1023S-1028S.
29. Vanhala M., Saltevo J., Soininen P., et al. Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study. Am J Epidemiol 2012, 176:253-260.
30. Wijendran V., Hayes K.C. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 2004, 24:597-615.
31. Griffin M.D., Sanders T.A., Davies I.G., et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 2006, 84:1290-1298.
32. Harris W.S. The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep 2006, 8:453-459.
33. Livingstone M.B., Black A.E. Markers of the validity of reported energy intake. JNutr 2003, 133(Suppl.3):895S-920S.